Clinical Trial Update: Bevacizumab for Central Retinal Vein Occlusion Study [Phase 3]

View source ↗

Summary

This entry indicates that a Phase 3 trial of bevacizumab for central retinal vein occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Anders Kvanta | Conditions: Central Retinal Vein Occlusion | Phase 3 | Status: COMPLETED